reports

12

Oct'21

The nuclear medicine and radiopharmaceutical manufacturing market is estimated to be more than USD 6 billion in 2030, predicts Roots Analysis

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has …

Read More
Copyrights © 2020 Blavida.
Skip to toolbar